Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
DENTSPLY SIRONA ( (XRAY) ) has provided an announcement.
On September 19, 2025, DENTSPLY SIRONA‘s Board approved a one-time retention equity incentive award for executives, including Tony Johnson, to recognize his performance during a leadership transition. The award, valued at $2 million in stock options, aims to retain Johnson for three years, with options vesting on the third anniversary and expiring ten years from the grant date.
The most recent analyst rating on (XRAY) stock is a Hold with a $14.50 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.
Spark’s Take on XRAY Stock
According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.
DENTSPLY SIRONA’s overall stock score reflects significant financial challenges, with declining revenues and profitability weighing heavily. Technical indicators suggest a bearish trend, and valuation concerns persist due to negative earnings. However, the earnings call provided some positive insights into operational improvements, and recent corporate events may enhance strategic positioning.
To see Spark’s full report on XRAY stock, click here.
More about DENTSPLY SIRONA
DENTSPLY SIRONA Inc. operates in the dental industry, providing a range of dental products and technologies. The company focuses on delivering innovative solutions for dental professionals and enhancing patient care globally.
Average Trading Volume: 3,174,107
Technical Sentiment Signal: Sell
Current Market Cap: $2.68B
Find detailed analytics on XRAY stock on TipRanks’ Stock Analysis page.